Esmée P Hoefsmit (E P Hoefsmit, Esmee P Hoefsmit)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Cell Proliferation

Dendritic Cells

Liver Metastases

Top Venues

Cancer research communications

Journal for immunotherapy of cancer

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Esmée P Hoefsmit, Paula T van Royen, Disha Rao, Johanna A Stunnenberg, Petros Dimitriadis, Cor Lieftink, Ben Morris, Elisa A Rozeman, Irene L M Reijers, Ruben Lacroix, Huma Shehwana, Maarten A Ligtenberg, Roderick L Beijersbergen, Daniel S Peeper, Christian U Blank
Inhibitor of apoptosis proteins (IAP) antagonist induces T-cell proliferation after cross-presentation by dendritic cells. Cancer immunology research (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Elisa A Rozeman, Judith M Versluis, Karolina Sikorska, Esmée P Hoefsmit, Petros Dimitriadis, Disha Rao, Ruben Lacroix, Lindsay G Grijpink-Ongering, Marta Lopez-Yurda, Birthe C Heeres, Bart A van de Wiel, Claudie Flohil, Aysegul Sari, Stijn W T P J Heijmink, Daan van den Broek, Annegien Broeks, Jan Willem B de Groot, Marieke A Vollebergh, Sofie Wilgenhof, Johannes V van Thienen, John B A G Haanen, Christian U Blank
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation. Journal for immunotherapy of cancer 11 (7) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Tim B Fessenden, Lauren E Stopfer, Fiona Chatterjee, Julian Zulueta, Josh Mesfin, Therese Cordero Dumit, Irene Reijers, Esmée P Hoefsmit, Christian Blank, Forest White, Stefani Spranger
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins. Journal for immunotherapy of cancer 10 (7) (2022)
Esmée P Hoefsmit, Elisa A Rozeman, Trieu My Van, Petros Dimitriadis, Oscar Krijgsman, Jordan W Conway, Ines Pires da Silva, Jacqueline E van der Wal, Steven L C Ketelaars, Kaspar Bresser, Annegien Broeks, Ron M Kerkhoven, Jason W Reeves, Sarah Warren, Pia Kvistborg, Richard A Scolyer, Ellen W Kapiteijn, Daniel S Peeper, Georgina V Long, Ton N M Schumacher, Christian U Blank
Comprehensive analysis of cutaneous and uveal melanoma liver metastases. Journal for immunotherapy of cancer 8 (2) (2021)
E A Rozeman, Esmée P Hoefsmit, I L M Reijers, Robyn P M Saw, J M Versluis, O Krijgsman, Petros Dimitriadis, K Sikorska, B A van de Wiel, H Eriksson, M Gonzalez, A Torres Acosta, L G Grijpink-Ongering, Kerwin F Shannon, John B A G Haanen, J Stretch, S Ch'ng, Omgo E Nieweg, H A Mallo, S Adriaansz, R M Kerkhoven, S Cornelissen, A Broeks, W M C Klop, C L Zuur, W J van Houdt, Daniel S Peeper, Andrew J Spillane, A C J van Akkooi, Richard A Scolyer, Ton N M Schumacher, A M Menzies, G V Long, Christian U Blank
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma. Nature medicine 27 (2) (2021)
Jake S O'Donnell, Esmée P Hoefsmit, Mark J Smyth, Christian U Blank, Michele W L Teng
The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (19) (2019)
Esmée P Hoefsmit, Elisa A Rozeman, John B A G Haanen, Christian U Blank
Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events. ESMO open 4 (4) (2019)